-
Social Determinants of Health Affecting Response to Opioid Addiction Treatment
Sep 9, 2025, 16:22 PM -
Excel Front-End, R Back-End: A Gateway to Faster Individual Patient Simulations and Probabilistic Sensitivity Analyses in Cost-Effectiveness Models for HTA
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Turning SAP Feedback into HTA-Ready Action: A Semi-Automated Approach for RWD Studies
Sep 9, 2025, 16:22 PM -
Years of Life Lost and Productivity TB1 SY2 Costs Due to Premature Cancer-Related Mortality in Morocco
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the United Arab Emirates
Sep 9, 2025, 16:22 PM -
Mapping the Burden of Seizure Emergencies in Spain: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Current Methodological Practices to Define Within-Patient Meaningful Change in Rare Diseases: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Budget Impact of the VELYS™ Robotic-Assisted Solution Compared to Manual Procedure in Patients Undergoing Primary Total Knee Arthroplasty in Italy
Sep 9, 2025, 16:22 PM -
Navigating the Influence of Traditional Chinese Medicine (TCM) on the Positioning of New Treatments in China: A Review of TCM Inclusion in Clinical Guidelines
Sep 9, 2025, 16:22 PM -
Examining The Relationship Between Diabetes Mellitus and Eating Disorders
Sep 9, 2025, 16:22 PM -
Cardiovascular Event Rates and Mortality Among Secondary-Prevention Hypercholesterolemia Patients in Japan
Sep 9, 2025, 16:22 PM -
Early Outpatient Follow-Up and Reduced Health Care Resource Utilization in Acute Heart Failure in Germany: A Descriptive Analysis
Sep 9, 2025, 16:22 PM -
Role of Real-World Evidence (RWE) in Pricing and Reimbursement Decisions for Rare Disease in Health Technology Assessment (HTA) Submissions Across EU4 + UK
Sep 9, 2025, 16:22 PM -
Is There a Lack of Dietary Data Collection in Real-World IBD Studies? Literature Review and Future Considerations
Sep 9, 2025, 16:22 PM -
Risk, Time in Hospital, and Associated Costs? of Hospitalizations in Individuals With Infantile-Onset SMA: Results From DEVOTE Part B
Sep 9, 2025, 16:22 PM -
AI in Evidence Synthesis: Have We Reached the Promised Land or Are We Still Wandering the Desert?
Sep 9, 2025, 16:22 PM -
Systematic Literature Review and Bayesian Network Meta-Analysis of Sugemalimab Plus Chemotherapy vs. Other First-Line Treatments for Metastatic Non-Small Cell Lung Cancer Without Sensitizing eGFR, ALK, ROS1, or RET Alterations
Sep 9, 2025, 16:22 PM -
What Did Time Reveal Evaluating the Accuracy of Parametric Model Predictions Against Long-Term Observed Data for Larotrectinib?
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Metastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM
